Advertisement
Screener

HERSHEY CO (HSY) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

HERSHEY CO Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

HERSHEY CO (HSY) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $1.29 million for the 3-month period ending 2015-10-04, per its 10-Q filed 2015-10-30.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2015-10-30

  • HERSHEY CO derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-10-04 was $1.29M, a 49.55% decline year-over-year.
  • HERSHEY CO derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-07-05 was $1.14M, a 256.56% increase year-over-year.
  • HERSHEY CO derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-04-05 was -$287.00K.
  • HERSHEY CO derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2014-12-31 was $37.00K.
  • HERSHEY CO derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was $2.50M, a 22.93% decline from fiscal 2013.
  • HERSHEY CO derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2013 was $3.24M.
Period endDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month
2015-10-04$1.29M
10-Q · filed 2015-10-30
$2.43M
derived: sum of 2 quarters · filed 2015-10-30
$2.14M
10-Q · filed 2015-10-30
$2.18M
derived: sum of 4 quarters · filed 2015-10-30
2015-07-05$1.14M
10-Q · filed 2015-08-07
$854.00K
10-Q · filed 2015-08-07
$891.00K
derived: sum of 3 quarters · filed 2015-08-07
$3.44M
derived: sum of 4 quarters · filed 2015-10-30
2015-04-05-$287.00K
10-Q · filed 2015-05-01
-$250.00K
derived: sum of 2 quarters · filed 2015-05-01
$2.30M
derived: sum of 3 quarters · filed 2015-10-30
$2.62M
derived: sum of 4 quarters · filed 2015-10-30
2014-12-31$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20
$2.59M
derived: sum of 2 quarters · filed 2015-10-30
$2.91M
derived: sum of 3 quarters · filed 2015-10-30
$2.50M
10-K · filed 2015-02-20
2014-09-28$2.55M
10-Q · filed 2015-10-30
$2.87M
derived: sum of 2 quarters · filed 2015-10-30
$2.46M
10-Q · filed 2015-10-30
$2.43M
derived: sum of 4 quarters · filed 2015-10-30
2014-06-29$320.00K
10-Q · filed 2015-08-07
-$92.00K
10-Q · filed 2015-08-07
-$122.00K
derived: sum of 3 quarters · filed 2015-08-07
$3.03M
derived: sum of 4 quarters · filed 2015-08-07
2014-03-30-$412.00K
10-Q · filed 2015-05-01
-$442.00K
derived: sum of 2 quarters · filed 2015-05-01
$2.71M
derived: sum of 3 quarters · filed 2015-05-01
$2.87M
derived: sum of 4 quarters · filed 2015-05-01
2013-12-31-$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20
$3.13M
derived: sum of 2 quarters · filed 2015-02-20
$3.28M
derived: sum of 3 quarters · filed 2015-02-20
$3.24M
10-K · filed 2015-02-20
2013-09-29$3.16M
10-Q · filed 2014-10-31
$3.31M
derived: sum of 2 quarters · filed 2014-10-31
$3.27M
10-Q · filed 2014-10-31
2013-06-30$155.00K
10-Q · filed 2014-08-01
$115.00K
10-Q · filed 2014-08-01
2013-03-31-$40.00K
10-Q · filed 2014-05-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
SANFILIPPO JOHN B & SON INC (JBSS)United States$0.545B4.66
Rocky Mountain Chocolate Factory, Inc. (RMCF)United States$0.008B-3.43